TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05127993

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Passive Talaris Demonstrator
Description: The amputee will walk with the passive Talaris Demonstrator, a novel prosthetic foot, designed and built by Axiles Bionics.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Passive Talaris Demonstrator
Description: The amputee will walk with the passive Talaris Demonstrator, a novel prosthetic foot, designed and built by Axiles Bionics.
Study: NCT04356859

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Albumin Human
Description: Addition of albumin during acute resuscitation following burn injury
Study: NCT04566159

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBI-CHW
Description: 2 sessions of computer delivered counseling + nicotine replacement therapy and CHW follow up post hospitalization up to twice weekly for up to 8 weeks

Intervention type: OTHER
Group type: OTHER
Intervention: Standard Care
Description: Standard tobacco treatment care offered by the inpatient care
Study: NCT05312125

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: backward downhill walking
Description: Children in the intervention group will take backward downhill walking program plus to routine physiotherapy.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: routine physiotherapy
Description: Children in one of the groups will take routine physiotherapy programme

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: routine physiotherapy
Description: Children in one of the groups will take routine physiotherapy programme
Study: NCT04848662

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BDA MDI (PT027) 160/180 μg
Description: Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 80/90 μg per puff. Two puffs to administer 160/180 μg dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BDA MDI (PT027) 160/180 μg
Description: Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 80/90 μg per puff. Two puffs to administer 160/180 μg dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pulmicort Respules 0.5 MG/ML Inhalation Suspension
Description: Budesonide 0.5 mg/ml. Each 2 ml Respule contains 1 mg budesonide.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pulmicort Respules 0.5 MG/ML Inhalation Suspension
Description: Budesonide 0.5 mg/ml. Each 2 ml Respule contains 1 mg budesonide.
Study: NCT04815486

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: Active rTMS in 10 daily sessions in two weeks of sequential application of: 90% RMT at 1Hz, 1000 pulses/day, 25s inter train on M1 of lesioned hemisphere and 90% RMT at 10Hz, 1000 pulses/day, 50s inter train on M1 of healthy hemisphere.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Motor Imagery (MI) through a Brain-Computer Interface (BCI) training platform in Virtual Reality (VR) with NeuRow
Description: It will consist of a combination of the bilateral rTMS protocol and the MI-neurofeedback training. During this therapy, the patient received 10 consecutive daily sessions of bilateral rTMS (Monday to Friday, two weeks), with the same stimulation parameters as another therapy, and 12 non-consecutive sessions of MI-neurofeedback (three times a week for four weeks). The first 6 MI-neurofeedback sessions were carried out after bilateral stimulation with rTMS (i.e., rTMS as a priming method during the first two weeks), and the last 6 sessions, without rTMS as prior priming during the last two weeks.
Study: NCT04876885

Intervention type: OTHER
Group type: OTHER
Intervention: Educational video
Description: Three two-minute educational videos about COVID-19 vaccine development and dissemination

Intervention type: OTHER
Group type: OTHER
Intervention: Educational video
Description: Three two-minute educational videos about COVID-19 vaccine development and dissemination
Study: NCT05980819

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sustainability lecture and opportunity to create a project
Description: Pure education
Study: NCT06348745

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ultrasound
Description: 5. Transthoracic ultrasound for both right and left diaphragm during inspiration and expiration.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ultrasound
Description: 5. Transthoracic ultrasound for both right and left diaphragm during inspiration and expiration.
Study: NCT06053047

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bluedrop Monitoring Service (BMS)
Description: Remote use of ThermoVisual monitoring
Study: NCT05858398

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: pharmacokinetics blood sample assessment
Description: pharmacokinetics blood sample assessment during the first exposure to docetaxel
Study: NCT04840498

Intervention type: BEHAVIORAL
Intervention: Autism Research
Description: Measuring aspects such as self esteem, social skills, and social anxieties.

Intervention type: BEHAVIORAL
Intervention: Autism Research
Description: Measuring aspects such as self esteem, social skills, and social anxieties.
Study: NCT05424094

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: multi-professional group programme 'kinderleicht'
Description: 12-16 children/adolescents who participate in the multi-professional group programme 'kinderleicht' receive coaching in the areas of behaviour, exercise, nutrition and medicine from qualified professionals on fridays during 11 months.
Study: NCT05526222

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jaktinib Hydrochloride Tablet
Description: Orally administered, twice a day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jaktinib Hydrochloride Tablet
Description: Orally administered, twice a day

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Jaktinib Hydrochloride Tablet
Description: Orally administered, twice a day
Study: NCT06376032

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EndeavorOTC®
Description: EndeavorOTC is an over the counter digital therapeutic designed to improve attention function as measured by computer-based testing in patients 18 and older with primarily inattentive or combined type ADHD, who have a demonstrated attention issue. EndeavorOTC utilizes the same proprietary technology underlying EndeavorRx®, an FDA-authorized prescription digital therapeutic indicated to improve attention function in children ages 8-17. EndeavorOTC is deployed on mobile devices and incorporates adaptive, simultaneous cognitive tasks in a consumer-grade action videogame-based platform with high-quality graphics and reward mechanisms.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EndeavorOTC®
Description: EndeavorOTC is an over the counter digital therapeutic designed to improve attention function as measured by computer-based testing in patients 18 and older with primarily inattentive or combined type ADHD, who have a demonstrated attention issue. EndeavorOTC utilizes the same proprietary technology underlying EndeavorRx®, an FDA-authorized prescription digital therapeutic indicated to improve attention function in children ages 8-17. EndeavorOTC is deployed on mobile devices and incorporates adaptive, simultaneous cognitive tasks in a consumer-grade action videogame-based platform with high-quality graphics and reward mechanisms.
Study: NCT04938934

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lipids infusion
Description: Lipids infusion via intestinal tube

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham infusion
Description: Sham infusion via intestinal tube
Study: NCT05313815

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Moderate hypofractionated boost to the prostate with pelvic RT (external beam radiotherapy)
Description: External beam radiotherapy- 60 Gy in 20 fractions to the prostate, 48 Gy in 20 fractions to the pelvis, 68 Gy in 20 fraction optional boost to prostatic dominant intraprostatic lesion, 55 Gy in 20 fraction optional boost to involved pelvic lymph nodes
Study: NCT04705519

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel Combined With Bevacizumab
Description: Nab-paclitaxel 150mg/m2 ，iv drip, d1, Bevacizumab 5mg/kg, iv drip, d1, q2w.
Study: NCT05647109

Intervention type: OTHER
Intervention: No intervention
Description: No intervention

Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study: NCT05657132

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: herbal intracanal medication paste
Description: study the effect of costus herbal paste on enterococcus faecalis bacteria

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Meta paste
Description: compare the effect of Costus paste with meta paste in reducing the number of enterococcus faecalis
Study: NCT06620432

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Low segment hysterotomy
Description: A low segment hysterotomy is a surgical procedure in which an incision is made in the lower segment of the uterus, typically during a cesarean section or other uterine surgeries. This approach is preferred because the lower uterine segment is thinner and less vascular, reducing the risk of bleeding and complications during and after the procedure. The incision is typically horizontal.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low segment hysterotomy
Description: A low segment hysterotomy is a surgical procedure in which an incision is made in the lower segment of the uterus, typically during a cesarean section or other uterine surgeries. This approach is preferred because the lower uterine segment is thinner and less vascular, reducing the risk of bleeding and complications during and after the procedure. The incision is typically horizontal.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High segment hysterotomy
Description: A high segment hysterotomy is a surgical procedure involving an incision in the upper segment of the uterus.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High segment hysterotomy
Description: A high segment hysterotomy is a surgical procedure involving an incision in the upper segment of the uterus.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Crossed hysterorrhaphy
Description: Crossed hysterorrhaphy is a surgical technique used to close the uterine incision following a hysterotomy, particularly during cesarean sections. In this method, the sutures are placed in a crossed or X-shaped pattern, which helps to evenly distribute tension across the incision site.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Crossed hysterorrhaphy
Description: Crossed hysterorrhaphy is a surgical technique used to close the uterine incision following a hysterotomy, particularly during cesarean sections. In this method, the sutures are placed in a crossed or X-shaped pattern, which helps to evenly distribute tension across the incision site.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non-Crossed hysterorrhaphy
Description: Non-crossed hysterorrhaphy is a surgical technique used to close a uterine incision, typically after a hysterotomy, such as during a cesarean section. In this method, the sutures are placed in a linear, parallel fashion rather than in a crossed or X-shaped pattern

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non-Crossed hysterorrhaphy
Description: Non-crossed hysterorrhaphy is a surgical technique used to close a uterine incision, typically after a hysterotomy, such as during a cesarean section. In this method, the sutures are placed in a linear, parallel fashion rather than in a crossed or X-shaped pattern
Study: NCT06309849

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual physiotherapy intervention( cervical traction, suboccipital release, muscle energy technique)
Description: Manual physiotherapy intervention( cervical traction, suboccipital release, muscle energy technique) strengthening exercises for neck muscles, ultrasound with parameters 5 min × 3 times × 4 weeks, 1 MHz, continuous: 1.5 W/cm2; pulsed: 2.5 W/cm2.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Manual physiotherapy intervention( cervical traction, suboccipital release, muscle energy technique)
Description: Manual physiotherapy intervention( cervical traction, suboccipital release, muscle energy technique) strengthening exercises for neck muscles, ultrasound with parameters 5 min × 3 times × 4 weeks, 1 MHz, continuous: 1.5 W/cm2; pulsed: 2.5 W/cm2.
Study: NCT06086522

Intervention type: DRUG
Group type: OTHER
Intervention: QN-302
Description: Phase 1 dose-finding study, the study design is for QN-302 to be given once a week, intravenously over 60 min, on Day 1, Day 8, and Day 15 of a 28-Day cycle.

Intervention type: DRUG
Group type: OTHER
Intervention: QN-302
Description: Phase 1 dose-finding study, the study design is for QN-302 to be given once a week, intravenously over 60 min, on Day 1, Day 8, and Day 15 of a 28-Day cycle.
Study: NCT06102798

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acunpuncture
Description: For the bilateral BL25, sterile disposable steel needles (Hwato, China; 0.3 mm×75 mm) will be inserted through adhesive pads to a depth of 50-70mm until participates feel a sensation similar to electric shock radiating downward to the knees. For the other four acupoints (BL23, BL40, BL57 and KI3), the needles (Hwato, China; 0.3 mm×40 mm) will be inserted through adhesive pads to a depth of 15-25 mm, gently rotated three times and lifted to achieve de qi.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham acupuncture
Description: For all the points, the needles will be inserted into adhesive pads without skin penetration. Needles will be lifted, thrust and twirled for 3 times to mimic real acupuncture. No manipulation will be conducted during 30-minute maintenance.
Study: NCT04816097

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone phosphate
Description: 4 doses of dexamethasone 6mg IM 48h before elective CS.
Study: NCT04845061

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nebivolol Tablets
Description: cardio selective beta-1 blocker

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nebivolol Tablets
Description: cardio selective beta-1 blocker
Study: NCT06099314

Intervention type: DRUG
Intervention: Fruquintinib+PD-1 inhibitors
Description: Third-line treatment with fruquintinib combined with PD-1 inhibitors. Fruquintinib: 5mg,Oral once daily,2 weeks on/1 week off,Q3W； PD-1 inhibitor：for example, Sintilimab,iv,200mg, Q3W.

Intervention type: DRUG
Intervention: Fruquintinib+TAS-102
Description: Fourth-line treatment with fruquintinib combined with TAS-102 . Fruquintinib: 3-5mg(Depending on the patient's physical condition), Oral once daily,3 weeks on/1 week off,Q4W； TAS-102:orally, 35mg/m2 twice daily (maximum dose 80mg in a single dose) for days 1-5, repeated every 14 days.
Study: NCT05743218

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: electropuncture
Description: Electroacupuncture (EA) is a method of treating diseases by inserting a needle (usually a filiform needle) into the skin or tissue of a patient at a certain Angle, and then passing through the needle (sensing) micro-current waves of human bioelectricity to stimulate specific parts of the human body (acupoints).~1. Disposable sterile acupuncture filiform needle (0.16mm×13mm, 0.30mm×25mm, 0.30mm× 40mm), Guizhou Andi Medical Equipment Co, LTD, Guizhou Food and Drug Supervision and Equipment Production Xu 20170011.~2. Electroacupuncture apparatus: SDZ-Ⅱ electroacupuncture apparatus of Huatuo brand, Suzhou Medical Supplies Factory Co., LTD., Registration No. : 20172270675.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: electropuncture
Description: Electroacupuncture (EA) is a method of treating diseases by inserting a needle (usually a filiform needle) into the skin or tissue of a patient at a certain Angle, and then passing through the needle (sensing) micro-current waves of human bioelectricity to stimulate specific parts of the human body (acupoints).~1. Disposable sterile acupuncture filiform needle (0.16mm×13mm, 0.30mm×25mm, 0.30mm× 40mm), Guizhou Andi Medical Equipment Co, LTD, Guizhou Food and Drug Supervision and Equipment Production Xu 20170011.~2. Electroacupuncture apparatus: SDZ-Ⅱ electroacupuncture apparatus of Huatuo brand, Suzhou Medical Supplies Factory Co., LTD., Registration No. : 20172270675.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: electropuncture
Description: Electroacupuncture (EA) is a method of treating diseases by inserting a needle (usually a filiform needle) into the skin or tissue of a patient at a certain Angle, and then passing through the needle (sensing) micro-current waves of human bioelectricity to stimulate specific parts of the human body (acupoints).~1. Disposable sterile acupuncture filiform needle (0.16mm×13mm, 0.30mm×25mm, 0.30mm× 40mm), Guizhou Andi Medical Equipment Co, LTD, Guizhou Food and Drug Supervision and Equipment Production Xu 20170011.~2. Electroacupuncture apparatus: SDZ-Ⅱ electroacupuncture apparatus of Huatuo brand, Suzhou Medical Supplies Factory Co., LTD., Registration No. : 20172270675.
Study: NCT06441552

Intervention type: OTHER
Intervention: non-interventional
Description: non-interventional

Intervention type: OTHER
Intervention: non-interventional
Description: non-interventional

Intervention type: OTHER
Intervention: non-interventional
Description: non-interventional
Study: NCT04712656

Intervention type: DEVICE
Intervention: CPAP therapy
Description: CPAP treatment of obstructive sleep apnea.
Study: NCT04649125

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: dose escalation
Description: single fraction dose escalation to the tumour

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: dose escalation
Description: single fraction dose escalation to the tumour
Study: NCT05087953

Intervention type: DIAGNOSTIC_TEST
Intervention: Head-Up Tilt table test
Description: Autonomic response assessment in the orthostatic head up tilt test.

Intervention type: DIAGNOSTIC_TEST
Intervention: Head-Up Tilt table test
Description: Autonomic response assessment in the orthostatic head up tilt test.

Intervention type: DIAGNOSTIC_TEST
Intervention: Head-Up Tilt table test
Description: Autonomic response assessment in the orthostatic head up tilt test.

Intervention type: DIAGNOSTIC_TEST
Intervention: Heart Rate Variability
Description: Assessment of heart rate variability on 24-hour Holter monitoring..
Study: NCT06061172

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: gp-multitool.de
Description: The intervention is based on a digital tool, which implements recommendations of the S3 guideline multimorbidity of the German College of General Practitioners and Family Physicians. The tool includes nine questionnaires addressing four dimensions of care:~1. preferences (including a. treatment goals, and b. involvement of other persons in decision making);~2. activities (including a. activities and participation, and b. social support);~3. treatment (including a. problems with medication, and b. treatment burden);~4. complaints (including a. pain, b. psychiatric disorders, and c. other complaints).~The GPs can send the questionnaires by email to the patients and the patients can fill out the questionnaires at their home or in the waiting room of the GP's practice using their own smartphones, tablets or computers. The digital tool also includes instructions for conducting a medication review. Results from talks between GPs and patients can be documented in the tool.
Study: NCT05812092

Intervention type: DEVICE
Intervention: CONDUIT Interbody Cervical System with DePuy Synthes Cervical Plating System
Description: CONDUIT Interbody Cervical System will be inserted between C2 through T1 and fixated using a DePuy Synthes Cervical Plating System at 1 or 2 levels.
Study: NCT05863091

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HiCardi+
Description: A patch-type electrocardiogram device is attached to a patient undergoing pulmonary function tests.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HiCardi+
Description: A patch-type electrocardiogram device is attached to a patient on a ventilator in an intensive care unit.
Study: NCT05087953

Intervention type: DIAGNOSTIC_TEST
Intervention: Heart Rate Variability
Description: Assessment of heart rate variability on 24-hour Holter monitoring..

Intervention type: DIAGNOSTIC_TEST
Intervention: Heart Rate Variability
Description: Assessment of heart rate variability on 24-hour Holter monitoring..
Study: NCT04826926

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Procedure/Surgery: Non Surgical Periodontal Therapy
Description: Conventional staging debridement (CSD) according to the severity of periodontal disease in 2 to 4 appointments at day 0, 7, 14 and 21.~Supra and subgingival scaling and polishing will be performed by the use of manual and ultrasonic instruments and oral hygiene instructions will be given. Patients will be instructed to use interdental brushes with appropriate size interdental brushes or dental floss when interdental embrasures will not allow for interdental brushing.
Study: NCT06050083

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hypnosis audio recordings
Description: Hypnosis recordings created by the investigators that guide participants through using hypnosis to manage chronic pain.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Hypnosis audio recordings
Description: Hypnosis recordings created by the investigators that guide participants through using hypnosis to manage chronic pain.
Study: NCT05259397

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07225570
Description: PF-07225570 given IVe in a 28-day cycle (as induction and maintenance regimen). Multiple dose levels will be evaluated.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07225570
Description: PF-07225570 given IVe in a 28-day cycle (as induction and maintenance regimen). Multiple dose levels will be evaluated.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07225570
Description: PF-07225570 given IVe in a 28-day cycle (as induction and maintenance regimen). Multiple dose levels will be evaluated.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07225570
Description: PF-07225570 given IVe in a 28-day cycle (as induction and maintenance regimen). Multiple dose levels will be evaluated.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sasanlimab
Description: Sasanlimab will be administered SQ on day 1 of each 28 day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sasanlimab
Description: Sasanlimab will be administered SQ on day 1 of each 28 day cycle.
Study: NCT04591964

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: mobile application M-Cardio based on android
Description: Mobile apllication M-Cardio (android) for remote monitoring of patients with CHF developed on algorithms of clinical indicators, that's give us to evaluate current condition of patient, depends from quantity points of abnormals higher or lower threshold values, with automatically notification for doctor and patient for timely medical service.